Form 4: Lemaitre Vascular Director Acquires Shares

Sentiment:

Insider Transaction Report


Lemaitre Vascular Director Bridget A. Ross acquired 477 shares of common stock through the vesting of performance share units and dividend equivalent rights.

Summary

  • Bridget A. Ross, a Director at Lemaitre Vascular Inc. (LMAT), acquired 476 shares of common stock on February 26, 2026.
  • These shares were acquired upon the settlement of a Performance Share Unit (PSU) award that was granted on December 6, 2024.
  • One-third of the PSU award vested on February 26, 2026, upon the determination of satisfaction of the performance condition.
  • The remaining balance of the PSU award will vest in equal annual installments on the grant date anniversary over the next two years.
  • An additional 1 share of common stock was acquired on February 26, 2026, due to the release of dividend equivalent rights (DERs) associated with the vesting PSU award.
  • Each dividend equivalent right is economically equivalent to one share of the Issuer's common stock.
  • Following these transactions, Bridget A. Ross beneficially owns 3,942 shares of Lemaitre Vascular Inc. common stock directly.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event, reflecting the routine vesting of performance-based equity awards for a director, which aligns their interests with the company's performance.

Positives

  • A director's equity awards vesting indicates the achievement of performance conditions, aligning management interests with shareholder value.
  • The acquisition of shares increases the director's direct ownership in the company, potentially signaling confidence.

Future Outlook

The remaining two-thirds of the Performance Share Unit award granted on December 6, 2024, will vest in equal annual installments on the grant date anniversary over the next two years.

Industry Context

StockSavvy.ai notes that the vesting and settlement of performance-based equity awards for directors and executives are standard compensation practices across industries. These transactions are routine and typically reflect the achievement of pre-defined performance metrics rather than discretionary open-market purchases.

Stakeholder Impact

  • Shareholders: Minor, as the vesting of equity awards is a standard component of executive and director compensation, potentially leading to slight dilution over time but also aligning interests.
  • Director (Bridget A. Ross): Positive, as she has received additional shares of common stock, increasing her direct ownership and personal stake in the company's performance.

Next Steps

  • The balance of the Performance Share Unit award will vest in equal annual installments on the grant date anniversary over the next two years.

Key Dates

DateDescription
12/06/2024Grant date of the Performance Share Unit (PSU) award to Bridget A. Ross.
02/26/2026Transaction date for the acquisition of common stock upon settlement of PSU award and release of dividend equivalent rights; 1/3 of the PSU award vested.
03/02/2026Date the Form 4 filing was signed by Laurie A. Churchill, Attorney-in-fact.

Keywords

Lemaitre Vascular, LMAT, Insider Transaction, Form 4, Equity Award, Performance Share Unit, PSU, Director, Stock Acquisition, Dividend Equivalent Rights

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.